carbostyril has been researched along with Colitis in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (27.78) | 18.2507 |
| 2000's | 5 (27.78) | 29.6817 |
| 2010's | 7 (38.89) | 24.3611 |
| 2020's | 1 (5.56) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, Y; Ge, Y; Guo, F; Guo, Z; Huang, L; Li, Y; Pan, Y; Song, Y; Yang, J; Yin, Y; Zhou, D; Zhu, W | 1 |
| Jang, H; Jang, WS; Jin, YW; Kim, H; Lee, C; Lee, J; Lee, SJ; Lee, SS; Myung, H; Myung, JK; Park, S; Shim, S | 1 |
| Bereshchenko, O; Cuzzocrea, S; Di Paola, R; Gentili, M; Gugliandolo, E; Migliorati, G; Riccardi, C; Ricci, E; Ronchetti, S | 1 |
| Boulouis, HJ; Caney, S; Cotard, JP; Dupree, G; Farca, AM; Fontaine, J; Kietzman, M; Lechowski, R | 1 |
| Harvey, BS; Nicotra, LL; Smid, SD; Vu, M | 1 |
| Hossain, MA; Ikeda, Y; Nagasaki, Y; Vong, LB; Yamashita, M | 1 |
| Dzierba, AL; Gershengorn, HB; Keene, A; Wunsch, H | 1 |
| Dong, J; Gong, J; Li, J; Li, Y; Shen, X; Sun, J; Wang, H; Zhao, J; Zhu, W; Zuo, L | 1 |
| Genta, RM | 1 |
| Kato, S; Nishio, H; Okayama, M; Takeuchi, K; Tsubouchi, R | 1 |
| Atsuda, K; Hibi, N; Matsui, H; Matsumoto, T; Nakamura, M; Takahashi, T; Tsuchimoto, K; Yamada, H | 1 |
| Hashiguchi, K; Hoshikawa, Y; Kanbe, T; Kurimasa, A; Mukoyama, T; Murai, R; Shimomura, T; Shiota, G; Tsuchiya, H; Yoshida, Y | 1 |
| Goto, S; Hara, K; Kondo, T; Makiyama, K; Murase, K; Sekine, I; Urata, Y; Zea-Iriarte, WL | 1 |
| Osaka, T; Sakurai, K; Yamasaki, K | 1 |
| Iwai, A; Iwashita, E | 1 |
| Berridge, B; Bouley, D; Braniecki, A; Willard, MD | 1 |
| Haruma, K; Kishimoto, S; Nakagawa, Y; Nakano, M; Sakurai, K; Tari, A | 1 |
| Evans, TG; Riley, D | 1 |
2 review(s) available for carbostyril and Colitis
| Article | Year |
|---|---|
Proper use of quinolones for canine colitis ambulatory treatment: literature review and REQUEST guidelines.
Topics: Animals; Anti-Bacterial Agents; Colitis; Dog Diseases; Dogs; Quinolones | 2013 |
Review article: the role of rebamipide in the management of inflammatory disease of the gastrointestinal tract.
Topics: Alanine; Anti-Ulcer Agents; Cells, Cultured; Clinical Trials as Topic; Colitis; Gastritis; Helicobacter Infections; Humans; Models, Biological; Quinolones | 2003 |
16 other study(ies) available for carbostyril and Colitis
| Article | Year |
|---|---|
Chylomicrons-Simulating Sustained Drug Release in Mesenteric Lymphatics for the Treatment of Crohn's-Like Colitis.
Topics: Administration, Oral; Animals; Chylomicrons; Colitis; Delayed-Action Preparations; Drug Delivery Systems; Female; Lymphatic System; Mesentery; Mice; Mice, Inbred C57BL; Nanoparticles; Quinolones; Rats; Rats, Sprague-Dawley; Tablets, Enteric-Coated | 2021 |
Rebamipide alleviates radiation-induced colitis through improvement of goblet cell differentiation in mice.
Topics: Alanine; Animals; Anti-Ulcer Agents; Cell Differentiation; Cell Proliferation; Colitis; Colon; Disease Models, Animal; Epithelial Cells; Gene Expression; Goblet Cells; HT29 Cells; Humans; Male; Mice, Inbred C57BL; Mucin-2; Quinolones; Radiation Injuries, Experimental; Radiation, Ionizing; Radiotherapy | 2018 |
Selective CB2 inverse agonist JTE907 drives T cell differentiation towards a Treg cell phenotype and ameliorates inflammation in a mouse model of inflammatory bowel disease.
Topics: Animals; Anti-Inflammatory Agents; Cell Differentiation; Colitis; Colon; Cytokines; Dioxoles; Disease Models, Animal; Inflammation; Inflammatory Bowel Diseases; Male; Mice, Inbred C57BL; Phenotype; Quinolones; Receptor, Cannabinoid, CB2; Spleen; T-Lymphocytes | 2019 |
Cannabinoid CB2 receptor activation attenuates cytokine-evoked mucosal damage in a human colonic explant model without changing epithelial permeability.
Topics: Arachidonic Acids; Biological Transport; Caco-2 Cells; Cannabinoid Receptor Agonists; Colitis; Colon; Colorectal Neoplasms; Dioxoles; Endocannabinoids; Epithelial Cells; Epithelium; Female; Humans; Hydrocortisone; Indoles; Inflammation; Interleukin-1beta; Intestinal Mucosa; Lymphocyte Count; Male; Permeability; Polyunsaturated Alkamides; Quinolones; Receptor, Cannabinoid, CB2; Tumor Necrosis Factor-alpha | 2013 |
Silica-installed redox nanoparticles for novel oral nanotherapeutics - improvement in intestinal delivery with anti-inflammatory effects.
Topics: Administration, Oral; Alanine; Animals; Anti-Inflammatory Agents; Colitis; Colon; Delayed-Action Preparations; Drug Carriers; Drug Compounding; Drug Liberation; Male; Mice, Inbred ICR; Nanoparticles; Nitrogen Oxides; Oxidation-Reduction; Quinolones; Silicon Dioxide | 2014 |
The association of antibiotic treatment regimen and hospital mortality in patients hospitalized with Legionella pneumonia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Azithromycin; Clostridium Infections; Cohort Studies; Colitis; Female; Hospital Costs; Hospital Mortality; Humans; Legionellosis; Length of Stay; Male; Middle Aged; Quinolones; Retrospective Studies; Treatment Outcome; United States; Young Adult | 2015 |
Laquinimod ameliorates spontaneous colitis in interleukin-10-gene-deficient mice with improved barrier function.
Topics: Animals; Colitis; Crohn Disease; Cytokines; Interleukin-10; Intestinal Mucosa; Leukocyte Common Antigens; Lymphocyte Count; Mice; Mice, Inbred C57BL; Mice, Knockout; NF-kappa B; Permeability; Quinolones | 2015 |
Protective effect of intra-rectal administration of rebamipide on dextran sulfate sodium-induced rat colitis.
Topics: Administration, Rectal; Alanine; Animals; Anti-Ulcer Agents; Anticoagulants; Colitis; Dextran Sulfate; Disease Models, Animal; Male; Quinolones; Rats; Rats, Wistar | 2004 |
Direct autoradiographic evidence that rebamipide interacts with neutrophils in dextran sulfate sodium induced colitis in rats.
Topics: Administration, Oral; Alanine; Animals; Anti-Ulcer Agents; Colitis; Dextran Sulfate; Disease Models, Animal; Goblet Cells; Indicators and Reagents; Male; Neutrophils; Quinolones; Rats; Rats, Wistar | 2005 |
Effect of rectal administration of rebamipide on dextran sulfate sodium-induced colitis: role of hepatocyte growth factor.
Topics: Administration, Rectal; Alanine; Animals; Anticoagulants; Apoptosis; Cell Proliferation; Colitis; Dextran Sulfate; Enzyme Inhibitors; Epithelial Cells; Female; Hepatocyte Growth Factor; Immunohistochemistry; In Situ Nick-End Labeling; Mice; Mice, Inbred BALB C; Quinolones | 2007 |
Impairment of antioxidants in colonic epithelial cells isolated from trinitrobenzene sulphonic acid-induced colitis rats. Protective effect of rebamipide.
Topics: Alanine; Analysis of Variance; Animals; Anti-Ulcer Agents; Antioxidants; Colitis; Culture Techniques; Disease Models, Animal; Glutathione; Glutathione Peroxidase; Glutathione Transferase; Intestinal Mucosa; Male; Quinolones; Random Allocation; Rats; Rats, Wistar; Trinitrobenzenesulfonic Acid | 1996 |
Protection by rebamipide against acetic acid-induced colitis in rats: relationship with its antioxidative activity.
Topics: Acetic Acid; Alanine; Animals; Anti-Ulcer Agents; Antioxidants; Colitis; Intestinal Mucosa; Lipid Peroxidation; Male; Neutrophils; Quinolones; Rats; Rats, Wistar; Reactive Oxygen Species | 1998 |
Changes in colonic inflammation induced by dextran sulfate sodium (DSS) during short- and long-term administration of rebamipide.
Topics: Acute Disease; Alanine; Animals; Anti-Inflammatory Agents; Anti-Ulcer Agents; Anticoagulants; Chronic Disease; Colitis; Colonoscopy; Dextran Sulfate; Drug Administration Schedule; Leukocyte Count; Male; Peroxidase; Quinolones; Rats; Rats, Sprague-Dawley | 1998 |
Possible antibiotic-associated colitis in a dog.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Colitis; Colon; Colonoscopy; Diarrhea; Dog Diseases; Dogs; Enrofloxacin; Fatal Outcome; Fluoroquinolones; Gastrointestinal Hemorrhage; Male; Quinolones | 1998 |
Rebamipide, an antiulcer drug, prevents DSS-induced colitis formation in rats.
Topics: Alanine; Animals; Anti-Ulcer Agents; Colitis; Colon; Dextran Sulfate; Disease Models, Animal; Interleukin-1; Interleukin-8; Male; Peroxidase; Quinolones; Rats; Rats, Wistar | 2000 |
Campylobacter laridis colitis in a human immunodeficiency virus-positive patient treated with a quinolone.
Topics: Adult; Campylobacter Infections; Colitis; Female; HIV Infections; Humans; Quinolones | 1992 |